DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION

Deva Holding A.S.

IBSE:DEVA Stock Report

Market Cap: ₺20.0b

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Deva Holding Past Earnings Performance

Past criteria checks 0/6

Deva Holding's earnings have been declining at an average annual rate of -13.6%, while the Pharmaceuticals industry saw earnings growing at 8% annually. Revenues have been growing at an average rate of 34% per year.

Key information

-13.56%

Earnings growth rate

-13.57%

EPS growth rate

Pharmaceuticals Industry Growth12.39%
Revenue growth rate33.95%
Return on equity-3.09%
Net Margin-4.84%
Last Earnings Update30 Jun 2026

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Deva Holding makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

IBSE:DEVA Revenue, expenses and earnings (TRY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2620,173-9765,5701,152
31 Mar 2619,709-9305,500995
31 Dec 2519,246-8075,4331,002
30 Sep 2521,4934495,9631,109
30 Jun 2521,8961155,851875
31 Mar 2520,8526725,653905
31 Dec 2420,234915,372814
30 Sep 2419,6774,7334,8791,997
30 Jun 2418,3874,5134,5152,027
31 Mar 2417,8495,4464,2381,746
31 Dec 2316,3594,8883,8161,548
30 Sep 2316,9593284,634408
30 Jun 2314,5231,2284,053384
31 Mar 2311,584-6143,141341
31 Dec 228,7138512,480313
30 Sep 223,7961,612790146
30 Jun 223,1721,426651132
31 Mar 222,6661,298544115
31 Dec 212,3301,17046974
30 Sep 212,13171140662
30 Jun 212,03776936766
31 Mar 211,92871332273
31 Dec 201,86365131281
30 Sep 201,68356929569
30 Jun 201,58343429550
31 Mar 201,54038329944
31 Dec 191,37428628139
30 Sep 191,31924526442
30 Jun 191,21621126144
31 Mar 191,10416725437
31 Dec 181,04113624136
30 Sep 1893712422839
30 Jun 1888611521131
31 Mar 1883610619432
31 Dec 178009318729
30 Sep 177706718218
30 Jun 177375917217
31 Mar 177176116513
31 Dec 166886015512
30 Sep 166675715017
30 Jun 166536114716
31 Mar 166225114315
31 Dec 155764813813
30 Sep 15549451339

Quality Earnings: DEVA is currently unprofitable.

Growing Profit Margin: DEVA is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: DEVA is unprofitable, and losses have increased over the past 5 years at a rate of 13.6% per year.

Accelerating Growth: Unable to compare DEVA's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: DEVA is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (10.4%).


Return on Equity

High ROE: DEVA has a negative Return on Equity (-3.09%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/18 18:36
End of Day Share Price 2026/09/18 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Deva Holding A.S. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide